ZFIN ID: ZDB-FISH-190201-1
Fish name: WT + MO1-washc4
Genotype: WT
Targeting Reagent: MO1-washc4
HUMAN DISEASE MODELED by WT + MO1-washc4
No data available
GENE EXPRESSION
Gene expression in WT + MO1-washc4
Reporter gene expression No data available
PHENOTYPE
Phenotype in WT + MO1-washc4
Phenotype Conditions Figures
autophagy decreased occurrence, abnormal chemical treatment by environment: ammonium chloride Fig. 7 with image from Kustermann et al., 2018
autophagy decreased occurrence, abnormal standard conditions Fig. 7 with image from Kustermann et al., 2018
blood circulation decreased magnitude, abnormal standard conditions Fig. 5 with image from Kustermann et al., 2018
heart edematous, abnormal standard conditions Fig. 5 with image from Kustermann et al., 2018
heart contraction decreased frequency, abnormal standard conditions Fig. 5 with image from Kustermann et al., 2018
heart contraction magnitude, normal standard conditions Fig. 5 with image from Kustermann et al., 2018
involuntary skeletal muscle contraction decreased occurrence, abnormal standard conditions Fig. 5 with image from Kustermann et al., 2018
motor neuron axon morphology, normal standard conditions Fig. 6 with image from Kustermann et al., 2018
myotome skeletal muscle cell has extra parts of type skeletal muscle cell vesicle, abnormal standard conditions Fig. 6 with image from Kustermann et al., 2018
proteasome-mediated ubiquitin-dependent protein catabolic process normal occurrence, normal standard conditions Fig. 7 with image from Kustermann et al., 2018
skeletal muscle mitochondrion malformed, abnormal standard conditions Fig. 6 with image from Kustermann et al., 2018
skeletal muscle sarcomere disorganized, abnormal standard conditions Fig. 6 with image from Kustermann et al., 2018
skeletal muscle sarcomere organization decreased process quality, abnormal standard conditions Fig. 6 with image from Kustermann et al., 2018
skeletal muscle cell has fewer parts of type skeletal muscle cell skeletal muscle myofibril, abnormal standard conditions Fig. 6 with image from Kustermann et al., 2018
skeletal muscle fiber development decreased process quality, abnormal standard conditions Fig. 6 with image from Kustermann et al., 2018
spinal cord axon development process quality, normal standard conditions Fig. 6 with image from Kustermann et al., 2018
spinal cord development process quality, normal standard conditions Fig. 6 with image from Kustermann et al., 2018
thigmotaxis decreased occurrence, abnormal standard conditions Fig. 5 with image from Kustermann et al., 2018
whole organism washc4 expression decreased amount, abnormal standard conditions Fig. 5 with image from Kustermann et al., 2018
whole organism atf4a expression increased amount, abnormal standard conditions Fig. 7 with image from Kustermann et al., 2018
whole organism ab1-map1lc3 labeling increased amount, abnormal chemical treatment by environment: ammonium chloride Fig. 7 with image from Kustermann et al., 2018
whole organism ab1-map1lc3 labeling increased amount, abnormal control Fig. 7 with image from Kustermann et al., 2018
whole organism ppp1r15a expression increased amount, abnormal standard conditions Fig. 7 with image from Kustermann et al., 2018
whole organism hspa5 expression increased amount, abnormal standard conditions Fig. 7 with image from Kustermann et al., 2018
whole organism Ab7-sqstm1 labeling increased amount, abnormal standard conditions Fig. 7 with image from Kustermann et al., 2018

CITATIONS  (1)